Antibodies to cyclic citrullinated peptide—ACCP. Arthritis, thanks to this analysis, is detected at any stage, including at the earliest stages.
Modern clinical and experimental immunology is able to conduct effective diagnostics for rheumatoid arthritis. The ACCP test makes it possible to obtain objective information about immunopathological changes and is an important tool in determining prognosis, diagnosis, determining activity and, accordingly, choosing a treatment method for arthritis and monitoring the effectiveness of ongoing therapy.
ACCP for rheumatoid arthritis is the determination of the ratio of antibodies to cyclic citrullinated peptide. What is citrulline? This is an important component in metabolism. It is formed by a separate amino acid called arginine during a biochemical reaction, although outside of stressful situations this product practically does not participate in protein synthesis and is eliminated from the body over time.
When a person is sick with arthritis, his body is subject to qualitative and quantitative changes, so if you remain inactive for some time, or let things take their course, citrulline, without outside help, will integrate into the amino acid protein chain, which directly affects the functioning of joint cartilage. When citrulline is in a normally functioning body, it is simply not perceived as a threat. Thus, the body protects itself and produces special antibodies to ACCP, which is facilitated by the immune system.
All ACCP indicators for rheumatoid arthritis are exclusively their own and represent a certain characteristic identifying sign of the disease. It is worth knowing that in addition to rheumatoid arthritis, there is also the presence of rheumatoid factor. It reveals itself when:
At the same time, 6% of healthy (by all other indicators) people also exhibit rheumatoid factor, which means the norm will be violated.
Diagnosis of ACCP in arthritis
Most medical luminaries believe that if rheumatoid factor is absent, then this is not at all an indicator of excellent health. It often has a hidden form, which does not make its presence known by symptoms. Then people have no idea what problems they have. In case of arthritis, the ACCP values increase to 31%.
Despite its popularity and prevalence in medical practice, ACCP is considered the most fastidious in comparison with similar tests.
Features of ACCP and its symptoms
The values of the ACCP test determine exclusively arthritis, because they simply do not exist for other diseases. The test indicates 99% of its presence, and the rest remains a share of dubious conclusions.
Venous blood for ACCP analysis is collected simply and quickly. The test procedure itself requires the presence of blood serum. In this regard, after collection is completed, the blood is placed in a special centrifuge. If it is not possible to make calculations in the laboratory immediately, then it is necessary to remember that the serum is stored in the refrigerator only for a week, no more. Permissible temperature - 2 - 85°C. In some cases, freezing at -200°C is allowed, only after this the whey cannot be defrosted and frozen again.
ACCP analysis procedure for arthritis
The analysis itself is carried out in test tubes. Cytofluometry is used here (a laser beam passes and is scattered in a different liquid medium). The results, in most cases, are ready the next day from the day of the ACDC analysis. Arthritis will be determined accurately, because during the analysis the norm in the patient’s blood will be determined, and possibly its violation.
Usually the norm is up to 3 – 3.1 U/ml. If this number is exceeded, we can safely say that the patient is sick, because this only happens with rheumatoid arthritis. Accordingly, the height of the indicator indicates the severity of the case and the complexity of the inflammatory process.
ACCP arthritis with rheumatism
The main purpose of ACCP is to predict and recognize the patient’s prospects of becoming infected and developing some kind of arthritis. This is incredibly convenient for prescribing treatment. Based on the test results, a drug treatment system and drugs that are optimally suited to a particular case are selected, and the treatment method itself is selected - hospital or outpatient. Today it is really very convenient!
The ACCP analysis has proven itself to be effective in difficult-to-coefficient reactive arthritis, which occurs when the body reacts to a urogenital or intestinal infection, as a result of which the joints become inflamed, but the infection does not enter them. This arthritis is very similar to its other varieties, and it is precisely the ACCP analysis that is called upon to determine that this is it. It determines the ratio of “friends” and “strangers” in the body.
Treatment can be considered successful and complete only after the analysis shows that the body has returned to normal. In the case where the norm is still violated, everything is repeated all over again and so on until complete recovery.
It is important to remember that only a doctor of appropriate specialization should examine and treat. Self-medication will not help with this, but can do harm.
And most importantly, take the ACCP analysis on time in order to identify the situation in time and take control of it.
What is an ACCP test? Citrulline is a product of human metabolism. It is formed from amino acids as a result of biochemical reactions. If a person is healthy, then citrulline in [...]
Why does joint pathology occur? This is an inflammatory lesion of the joints, which is based on the reaction of the body, namely the immune system, to any substances or cells. […]
Causes The causes of allergic arthritis are varied, since they synthesize the causes of arthritis and allergies. The main ones include: Symptoms Infectious allergic arthritis worsens after secondary […]
IgM classification Rheumatoid factor is an autoantibody, i.e. an antibody directed against the body's own tissues. Antibodies are specific proteins that attack foreign microorganisms and viruses that have entered the body […]
Causes of occurrence During the course of the disease, the cartilage tissue of joints, intervertebral discs, lumbosacral and sacroiliac joints is affected. Moreover, the damage is inflammatory, autoimmune in nature. Autoimmune inflammation is notable for […]
Effectiveness of treatment The result of using Anti Arthritis Nano can be felt from the first time. Improvement in general condition comes quite quickly. Using Anti Artrit Nano spray for joints, […]
Effectiveness of treatment Manufacturers guarantee that after 2 months of regular use of the product the following changes will be noted: joints will acquire their original elasticity; The process of restoring connective tissues will be significantly accelerated [...]
What is ANTI ARTRIT NANO? Arthritis is one of the most common diseases. Symptoms of the disease vary depending on the type: rheumatoid, reactive, infectious, traumatic arthritis, gouty […]
ANTI ARTRIT NANO remedy for arthritis. Where can I buy. Price. Reviews from doctors Degenerative processes in the joints quickly make themselves felt: the mobility of the nodes decreases, sudden […]
Arthritis medicine Anti Artrit Nano reviews, description Arthritis is included in the list of the most common diseases. Symptoms of the disease vary depending on the type: rheumatoid, reactive, infectious, […]
ACCP for rheumatoid arthritis is a modern diagnostic test method for RA disease, which allows you to determine the titer of antibodies to cyclic citrullinated peptide. This analysis is considered one of the most effective ways to determine the initial stage of development of rheumatoid arthritis in humans.
CCP antibodies are produced in the blood 1-1.5 years before the manifestation of acute symptoms of rheumatoid arthritis, while rheumatoid factor is detected in the blood serum already during the development of the inflammatory process.
Rheumatoid arthritis is a serious chronic autoimmune disease, manifested by acute inflammatory processes and severe pain in the affected joints. This disease can occur both in elderly people and in children from 1 year of age (with the juvenile form of the disease).
Rheumatoid arthritis is accompanied by the following pathological changes:
RA affects mainly small joints of the human musculoskeletal system, namely the metatarsophalangeal joints, joints of the hands, wrists, and elbows. Less commonly, the disease affects the knee and hip joints, which is typical for the seronegative type of rheumatoid lesion.
Arthritis of rheumatoid origin differs from other types of arthritis in that it can spread to other vital organs and systems of the patient, which significantly complicates the course of the disease.
The development of rheumatoid arthritis may be indicated by the following symptomatic manifestations:
When the level of CCP antibodies is elevated, the cartilage tissue covering the articular fragments is most often the first to be attacked. When the cartilage wears away, intense friction begins between the bones that make up the joint structure, which increases pain.
According to rheumatologist specialists, the success of therapy depends on the time of diagnosis of the disease, that is, the earlier the disease is identified, the greater the likelihood of a favorable treatment outcome.
To establish the correct diagnosis, the patient is recommended to undergo certain tests for rheumatoid arthritis.
Laboratory diagnostics using different examination methods effectively help identify rheumatoid arthritis.
The list of clinical tests includes the following laboratory tests:
Diagnosis of RA also uses the following instrumental research methods:
Citrulline is an autoantibody belonging to the IgG class, which is formed through impaired metabolic processes and is produced from arginine amino acids. This substance is completely eliminated from a healthy body, however, with the development of RA, the enzyme composition of human blood is modified, as a result of which the immune system detects citrulline cells and produces special antibodies - ACCP.
A blood test to determine ACCP is a characteristic marker of arthritic disease. Antibodies to cyclic citrullinated peptide are capable of recognizing antigens of various protein components containing the substance citrulline.
The ACCP test determines the process of disease development with up to 90% accuracy.
ACCP analysis is prescribed to the patient in the following cases:
The following diseases can be the causes of excess levels of CCP antibodies in the blood:
Specialists adhere to the following principles when conducting the ACDC test:
Increased levels of ACCP in rheumatoid arthritis; the norm for these indicators in a healthy person is 3 U/ml. The higher the level of CCP antibodies in the blood serum, the more intense rheumatoid arthritis develops and the progression of inflammatory processes.
The advantages of this study are the following factors:
A positive high level of ACCP makes it possible to diagnose rheumatoid arthritis at the initial stage of the disease, when X-ray images do not yet detect any visible changes in the structure of the bones and cartilaginous membrane.
A blood test for the presence of antibodies to cyclic citrullinated peptide helps to identify these risks:
Determining rheumatoid arthritis using the ACCP test allows you to develop the most effective and gentle therapeutic action plan.
When studying rheumatoid arthritis using the ACCP analysis and the rheumatoid factor (RF) analysis, experts adhere to this opinion:
The following video explains the diagnostic capabilities of rheumatoid arthritis:
There are many diseases of the skeletal system, one of the most common is rheumatoid arthritis. It is dangerous, so anyone who has encountered it should know what ACCP is for rheumatoid arthritis, the standard of analysis and when this study is carried out.
To correctly and quickly diagnose rheumatoid arthritis, an ACCP test is performed, the interpretation of which gives an idea of the state of antibodies to cyclic citrulline peptide. An RF test is also performed for rheumatoid factor.
The testing procedure allows us to identify the early stage of pathology. This technique gives the most accurate research results than, for example, RF, which is best performed against the background of long-term pathology.
The test allows you to understand the content of circulating markers in the blood, the amount of antibodies at a certain stage of the development of arthritis. The advantage of the ACCP test is that it is possible to diagnose any form of arthritis at any stage of the disease (the method does not detect other pathologies).
In order for the analysis for ACCP in rheumatoid arthritis to be as accurate as possible, you need to prepare for it:
The analysis procedure itself is simple: a specialist takes blood from a vein for analysis, extracts the serum, using the substance for further research.
The serum placed in a test tube is illuminated by a laser. The nature of the scattering of laser beams indicates the absence or presence of ACCP in the body. Results can be ready on the same day.
Testing confirms the development of arthritis, describes the course of the disease, indicates the stage of the pathology or indicates its absence.
Regardless of age, gender, the norm for this testing remains unambiguous - 3-3.1 U/ml. Changes may be minor and only in exceptional cases:
Taking into account the results of ACCP testing for rheumatoid arthritis, the doctor prescribes treatment and subsequent tests to monitor the decrease and addition of antibodies in the blood serum.
Having received an analysis of ACCP testing for rheumatoid arthritis, the specialist draws the appropriate conclusions:
The ACCP test for rheumatoid arthritis is safe. The price, of course, remains a bit expensive for many; depending on the laboratory’s prices, the status of the institution, and the urgency of the results, you will have to pay from 1,000 rubles to 1,700 rubles.
If the ACCP test for rheumatoid arthritis gives a positive result, there is no need to rush to conclusions. This technique has an error of 5%, so after analysis, the doctor may prescribe additional studies to verify the development of pathology.
It is important to remember that after treatment, the ACCP indicator will still remain high for some time, which does not indicate the effectiveness of the treatment, so other studies are needed here.
Rheumatoid arthritis is a fairly common autoimmune process that is characterized by persistent inflammation of the synovium and progressive destruction of the joints, which entails movement disorders and joint deformity.
During the first 6 years from the onset of the disease, most patients lose their ability to work and become disabled. In this regard, early diagnosis of rheumatoid arthritis occupies a special place.
For the purpose of laboratory diagnosis of RA, two methods are used: determination of the concentration of two autoantibodies - ACCP and a test for RF (rheumatoid factor). Since the specificity of the RF test is low, and its sensitivity directly depends on the duration of the pathological process, therefore the most promising marker of RA is the ACCP test.
Antibodies to cyclic citrulline-containing peptide are a group of IgG autoantibodies that have the ability to recognize abnormal peptides (epitopes containing the atypical amino acid citrulline.
Normally, citrulline is a common metabolite and is not incorporated into the peptide during the synthesis process. In RA, an autoimmune reaction occurs, during which the presence of the enzyme peptidylarginine deiminase stimulates the formation of citrulline-containing proteins in the synovial membrane, which triggers the production of autoantibodies.
The test for ACCP is an enzyme-linked immunosorbent assay (ELISA), using blood serum as a biomaterial for the study. The ACCP test for rheumatoid arthritis is very specific, indicating its value in the differential diagnosis of rheumatoid lesions in the early stages.
Blood is taken from a vein on an empty stomach; the interval between the last meal and the test should be approximately 8-12 hours.
It is forbidden to drink tea, coffee (especially with sugar), juice. You are only allowed to drink water. It is necessary to avoid smoking on the eve of the study.
Blood on ACCP, what is it? In short, this is a blood test for rheumatoid arthritis. This is a qualitatively new technique in the diagnosis of this disease. It consists of establishing the titer of ACCP antibodies to cyclic citrulline-containing peptide.
Citrulline is an amino acid that is formed during biochemical reactions from another amino acid - arginine. Normally, citrulline does not participate in protein synthesis and is excreted from the body. Rheumatoid arthritis causes a qualitative and quantitative restructuring of the enzyme composition in the body. As a result, citrulline begins to integrate into the amino acid peptide chain of joint cartilage tissue. The body's immune system perceives such a citrulline-containing peptide (protein) as foreign. As a response to its formation, the immune system begins to produce antibodies to the citrulline-containing cyclic peptide - anti-CCP.
ACCP has several Russian and English synonyms for the designation (ASSR, Anti-CCP, anti-TsCP). ACCP is a specific indicator of rheumatoid arthritis, today the most informative marker of early detection of the disease (detected in the blood one and a half years before the first signs of the disease appear). Previously, rheumatoid factor (RF), an antigen-immunoglobulin IgM complex, had a similar diagnostic value. But the specificity of rheumatoid factor is very low. It is detected not only in cases of rheumatoid arthritis, but also in other collagenoses: periarteritis nodosa, systemic lupus erythematosus, dermatomyositis. It is also found in tuberculosis, oncology, and severe liver diseases. In 5% of cases, RF is detected in practically healthy people in the absence of clinical symptoms of rheumatoid arthritis.
Negative RF indicators in the results of immunological tests do not exclude the presence of rheumatoid arthritis. In seronegative forms of the disease, RF is not detected. However, ACCP indicators are elevated in 30% of such cases, seronegative relative to the Russian Federation.
The specificity of ACCP for rheumatoid arthritis is about 98%.
The ACCP blood test is a new and high-quality diagnostic technique. In this case, we are talking about determining the titer of ACCP antibodies to cyclic citrullinated peptide. Citrulline is a product directly necessary for metabolism. Typically, it is formed from the amino acid arginine through a biochemical reaction. If you do not take into account critical situations, then citrulline does not take any part in protein synthesis and, accordingly, is simply excreted after a certain time.
It is worth immediately noting that the ACCP blood test is performed for rheumatoid arthritis. Therefore, during such a disease, some changes naturally occur in the body, in particular in quantitative and qualitative composition. Thus, if nothing is done, citrulline is independently integrated into the amino acid chain of proteins related directly to the work of articular cartilage. Such citrulline is not accepted in the body under normal conditions and normally functioning organs do not perceive it. Thus, the body, in defense, produces specific antibodies to ACCP with the help of the immune system.
Note that for rheumatoid arthritis, all diagnostic values of ACCP are specific. It can also be called a characteristic marker of this disease. We must also remember that in addition to rheumatoid arthritis, the so-called rheumatoid factor is also found in other collagenoses, as well as in severe lesions of tuberculosis, liver, malignant tumors and other neoplasms. But, despite this, almost 5% of healthy people may also have rheumatoid factor, and accordingly the norm will be absent.
Many doctors believe that the absence of rheumatoid factor does not always indicate a healthy body. Quite often it occurs in a latent form without the significance of additional symptoms. In this case, the person simply does not even realize that he already has health problems. Note that ACCP levels can be increased up to 30% in the presence of rheumatoid arthritis.
Summary of the article:
Antibodies to cyclic citrullinated peptide—ACCP. Arthritis, thanks to this analysis, is detected at any stage, including at the earliest stages.
ACCP for rheumatoid arthritis is, at the moment, the most informative test in modern laboratory diagnostics, the main principle of which is evidence-based medicine. The test is intended to determine the choice of optimal immunological methods for treating the disease in humans. ACCP detects circulating markers and autoantibodies at the time of exacerbation of inflammation.
ACCP for rheumatoid arthritis - the most reliable test
Rheumatoid arthritis is a common joint disease that affects connective tissue structures. The disease also spreads to small joints of the musculoskeletal system, that is, it is accompanied by polyarthritis. The cause of the disorders lies in autoimmune reactions, when the connective fibers of the joints are damaged under the influence of the body's immune system.
An important role in diagnosing rheumatoid arthritis is played by immunological laboratory tests and blood tests that detect the presence of specific antibodies. One of them is the ACDC test.
ACCP for rheumatoid arthritis is a modern method of diagnosing patients in whom this pathology is suspected. It is the most effective serological information marker of the disease and has been widely used over the past few years. The method is based on the use of synthetic citrulline peptide and research is being improved every year in order to increase its effectiveness. Today, the sensitivity of the test has been increased to 70-80%, and the specificity reaches 98%. Thanks to this accuracy, it is possible to diagnose a patient at an early stage of rheumatoid arthritis and begin treatment without waiting for complications and an increase in the extent of localization.
Citrulline is a product produced during metabolism in the body. It is formed from arginine amino acid during biochemical reactions. Under normal conditions, this substance does not take part in the production of protein and is excreted from the body. In the case of rheumatoid arthritis, a complete change in the enzyme composition occurs, both qualitative and quantitative. As a result, citrulline joins the amino acid chain of peptides in the cartilage tissue of the joint. As a result, proteins containing citrulline begin to be rejected by the body as foreign. A response occurs - the immune system produces specific antibodies to cyclic citrullinated peptide (ACCP).
Conducting a laboratory test for ACCP in rheumatoid arthritis guarantees early detection of the initiation of autoimmune processes in the patient’s body. The basis of this examination is the determination in blood samples using the flow cytometry technique of specific autoantibodies that interact with proteins that include the atypical amino acid citrulline.
Thanks to a significant breakthrough in the field of immunology, specialists were able to diagnose rheumatoid arthritis in a patient during the latent period.
At the present stage, this laboratory method is the second standard test for the immunological diagnosis of rheumatoid arthritis.
When autoimmune processes are launched in the human body, the process of citrullination of some filament proteins (filaggrin, vimentin) is observed, that is, citrulline (an intermediate product formed in the processes of urea metabolism) is included in the protein. This phenomenon is specific to the pathogenesis of rheumatoid arthritis and is key for serological diagnosis.
When autoimmune mechanisms are activated, the protective cells of the human body begin to produce specific monoclonal antibodies that are able to react and bind only one specific antigen.
In medical practice, these compounds are used to detect and eliminate specific antigens produced by citrullinated protein. Monoclonal antibodies to CCP in most cases belong to the immunoglobulin G class and are one of the most informative markers of rheumatoid arthritis, since they begin to be produced 1-1.5 years before the onset of clinical symptoms of the disease.
In the course of numerous studies, immunologists have found that monoclonal antibodies for rheumatoid arthritis recognize only the filaggrin protein (part of keratin), the structure of which includes citrulline.
With the development of an inflammatory reaction in the synovial membranes of a joint affected by rheumatoid arthritis, large quantities of citrullinated fibrin accumulate. Early detection of antigens formed in this situation guarantees high therapeutic success of specific therapy for rheumatoid arthritis.
For a long time, for laboratory diagnosis of rheumatoid arthritis, specialists prescribed general tests:
As the field of immunology has developed, the approach to the diagnostic process of this pathology has changed. Today, standard tests for early detection of the triggering of autoimmune mechanisms are as follows:
Venous blood is used to determine the level of ACCP.
The rapid development of serological diagnostic methods has led to the fact that today tests for the detection of ACCP are supplemented with new types of laboratory tests:
These tests help not only to differentiate the type of pathological process occurring in the affected joints, but also to make a preliminary prognosis in carrying out therapeutic measures.
What tests need to be taken in each clinical case are determined by the attending physician, who in this matter relies on the developed protocols for differential diagnosis.
The interpretation of the results obtained should also be carried out exclusively by a qualified specialist. The norm of indicators for such an examination in all categories of patients is the same - the content of specific antibodies should be in the range of 3-3.1 U/ml. In some clinical cases, the level of antibodies to CCP may exceed these figures, but the patient’s normal condition will not be violated:
Which results should be considered negative and which should be considered as confirmation of the development of rheumatoid arthritis in the patient is decided only by the attending physician.
What are the advantages of the ACCP tests performed? In addition to the early (1-1.5 years before the onset of pathological symptoms) detection of rheumatoid arthritis, this type of serological diagnosis helps determine the severity of this pathological process, as well as differentiate the inflammatory processes detected in the patient’s joints.
Examination of the patient for the level of ACCP allows one to predict the severity of destructive changes in the elements of the affected joint
The high specificity of this type of immunological study, supplemented by accompanying signs of pathology, determines high accuracy in making the correct diagnosis. For example, with positive test results for ACCP and C-reactive protein, rheumatoid arthritis is confirmed in 97% of patients.
Indications for seeking specialized help and conducting an examination for the presence of antibodies to CCP are necessary in cases of pain in the joints when the weather changes, or the presence of morning stiffness in the body, which persists for half an hour or more.
Early detection of the initiation of autoimmune processes in the patient’s body allows for timely initiation of specific therapy and prevention of irreversible changes in the structure of joints affected by rheumatoid arthritis. As a result, this helps prevent the patient from becoming disabled.
The study of ACCP (for the presence of anti-citrullinated antibodies) is the most modern and highly effective method for the early diagnosis of rheumatoid arthritis. Such antibodies are formed in the blood a year and a half before the disease begins to manifest itself with characteristic symptoms.
Other research methods can detect the disease much later, when the pathological process has already started, and getting rid of the disease becomes much more difficult.
ACCP is indicated for identifying seronegative forms of the disease (in which the rheumatoid factor is negative), differential diagnosis of diseases associated with joint damage and for assessing the risks of developing further deformations in the tissues.
Also, analysis and its interpretation are necessary for those who suffer from early forms of arthritis and for prescribing the most effective treatment.
Citrulline is a product of human metabolism. It is formed from amino acids as a result of biochemical reactions. If a person is healthy, then citrulline does not take part in the production of protein and is almost completely eliminated from his body.
With rheumatoid arthritis, the norm of the enzyme composition of the blood changes. The peptide containing the metabolic product is taken as foreign and in response to its occurrence the body begins to actively produce specific antibodies. This process occurs thanks to the coordinated work of the immune system.
ACCP is a whole group of heterogeneous antibodies that can recognize determinants of citrulline-containing protein antigens.
Doctors consider the value of this analysis to identify rheumatoid arthritis as a specific result and a unique marker of the disease.
Among all pathologies of the musculoskeletal system, rheumatoid arthritis, unfortunately, has become the most common ailment. Arthritis is a chronic autoimmune disease that manifests itself as an inflammatory process in the joints and the gradual development of degenerative and dystrophic changes in them. Extra-articular manifestations of the disease are also possible.
The main symptom of rheumatoid arthritis is damage to joint tissue. If a person develops this disease, he will experience the following symptoms:
In domestic medical centers and laboratories, you can do a special blood test for rheumatoid factor. However, at the moment it cannot be called reliable, because this factor can manifest itself in other diseases and inflammatory processes of a chronic nature.
If inflammation in the joint progresses, this causes deformation and loss of the ability to move normally. Therefore, differential diagnosis is extremely important.
The doctor should pay attention to the characteristic symptoms of arthritis, rheumatoid factor, the development of inflammation in the joints and the presence of CCP antibodies in the blood.
Testing specificity is up to 98 percent. In view of this, it is especially important for diagnosing arthritis, in contrast to other methods and rheumatic tests. The study is characterized by the ability to detect non-erosive and erosive forms of arthritis.
Antibodies to CCP are the main symptom of the onset of disease progression.
A person with inadequate levels of ACCP (when the norm is significantly exceeded) experiences severe damage to the cartilage of the joint.
It is this indicator that doctors use to predict the rate of destruction and deformation of cartilage tissue at the very beginning of the development of rheumatoid arthritis.
Blood for analysis is taken from the ulnar vein. To carry out the test, it is the serum that is needed (it is isolated using a centrifuge). The resulting material is stored for a week at a constant temperature of 2 to 8 degrees. The study itself is carried out in a test tube, using the method of scattering a laser beam in a liquid medium.
The accepted norm for ACCP is 3 U/ml. If the above result is obtained, then we are talking about the development of rheumatoid arthritis in a person. The transcript shows that the more the norm was exceeded, the more serious the inflammatory process in the joints.
The result and its value are used to predict the course of the disease and develop effective treatment methods.
The patient's ACCP level may remain at a high level even after getting rid of the pathology. For this reason, it cannot be used to evaluate the success of treatment.
Modern medicine provides for the appointment of ACCP testing for the diagnosis of rheumatoid arthritis:
With various rheumatic diseases, patients may also experience articular syndrome. It will significantly complicate the detection of the disease when conducting a blood test for rheumatic tests. Such people will especially benefit from the ACCP test for differential diagnosis.
With an increased ACCP, rapid development of erosions in cartilage tissue is observed. Therefore, the disease should be identified as early as possible and effective treatment undertaken. The analysis will make it possible to prevent the development of deformations, ankylosis and other irreversible pathologies in tissues.